Spotlight On... FDA nod for wireless continuous blood pressure, heart monitor for remote use; WSJ on artificial pancreas patient-hacks; NBA and GE award 6 R&D grants; and more...

Continuous monitoring of blood pressure typically requires an arterial catheter or other complex equipment--which means it's typically confined to critical care settings. But now, the FDA has cleared a low-pressure finger cuff that continuously monitors blood pressure beat-by-beat at an accuracy that exceeds the agency's requirement, according to its maker, Charlottesville, VA-based CareTaker Medical. It uses Pulse Decomposition Analysis technology to noninvasively measure blood pressure; it also measures heart rate as accurately as a 3-lead ECG. The finger cuff connects to a wrist-worn device; data can be viewed online or via an app. It can also be integrated into patient medical records. "CareTaker is a real game changer, allowing physicians to remotely monitor medical-grade Continuous Blood Pressure and Heart Rate from anywhere, using only a patient friendly-finger cuff," said Dr. Jay Sanders, adjunct professor of medicine at Johns Hopkins School of Medicine and president emeritus of the American Telemedicine Association. "Until now, most clinicians have had to settle for intermittent 'point-in-time' Blood Pressure measurements using bulky arm cuffs, which can produce misleading results due to the influence of many factors such as movement, posture, anxiety, or caffeine. In remote monitoring settings, the ability to gather continuous blood pressure and vital sign data from such an integrated easy-to-use device will provide better information and improve patient compliance while reducing cost and workload." More

> The Wall Street Journal has the latest article covering a patient-hacked artificial pancreas, citing impatience for industry to debut its own closed-loop diabetes tech. More

> The National Basketball Association (NBA) and GE Healthcare ($GE) have selected 6 awardees as part of their sports medicine and orthopedics collaboration for a total of more than $1.5 million in funding as part of a challenge on tendinopathy. The next call for research proposals on myotendinous injuries will be out in June. More

> Algorithmic music therapeutics startup The Sync Project has brought on a star-studded set of advisers including musicians Peter Gabriel, Annie Clark and Jon Hopkins, as well as composer and conductor Esa-Pekka Salonen. It also appointed former Biogen ($BIIB) EVP Steven Holtzman to its board. More

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.